Terms of use

SPRAYTIDE is not available to purchase. The site takes no orders, no payments and no reservations, and submitting the early-access form does not create any of those.

Requesting early access does not entitle you to buy the product, to a place in a queue, or to any particular price or date.

The formulation is not final. Ingredients, dose, frequency, presentation, classification and availability may all change, and any of them may change more than once.

The four concept identifiers shown on this site, ST-01 to ST-04, are placeholders for a product architecture. They are not confirmed formulations, and none of them is described as having any effect.

Nothing on this site is intended to diagnose, treat, cure or prevent any disease, and nothing on it should be used in place of advice from a qualified healthcare professional.

If you have a health condition, take medication, are pregnant or are breastfeeding, speak to a clinician before using any new product.

The evidence page records the status of every claim the brand could make. Where a claim requires substantiation that has not been reviewed, it does not appear on this site, and its absence is deliberate.

Any statement about absorption, patents or clinical performance will be published only after it has been substantiated and reviewed.

The SPRAYTIDE name, wave sign, wordmark and associated design system are the property of the brand owner. You may not reproduce them without permission.

Do not attempt to disrupt the site or submit the form by automated means. The form is rate-limited and submissions that look automated are discarded.

The site is provided as it stands, and information on it may be incomplete or out of date at any given moment.

The governing law, jurisdiction and limitation of liability applicable to these terms will be set out here once this document has been reviewed.